Early value dossiers for medical technologies
The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders
Recent news and posts
Two HTAs on robotic devices released in Finland
In October 2023, the FinCCHTA published on its website a Digi-HTA assessment aiming to evaluate two following robotic technologies:
- Lokomat robot-assisted walking rehabilitation device;
- Indego – Exoskeleton robot-assisted walking device.
According to the assessment subareas, both products received the following scores:
- Effectiveness – lack of sufficient data (1);
- Safety – sufficient (2);
- Costs – reasonable (2);
- Data security and data protection – lack of sufficient data (1);
- Usability and accessibility – sufficient (2).
The products received a total score of 08 (out of 10), which means the quality but insufficiency of available evidence and safety data. The cost of using the products could be high. There could be minor deficiencies in data security and protection or usability and accessibility.
See more information in Finnish here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.